These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 15215166

  • 21. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
    Peterson MR, Piao Z, Weidner N, Yi ES.
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
    [Abstract] [Full Text] [Related]

  • 22. Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.
    Li J, Zhang H, Lu Y, Chen Z, Su K.
    Int J Clin Exp Pathol; 2015 Dec; 8(5):5721-6. PubMed ID: 26191287
    [Abstract] [Full Text] [Related]

  • 23. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY, Fang WG, Zhong HH, Li Y, Zheng J, Du J, Heng WJ, Wu BQ.
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [Abstract] [Full Text] [Related]

  • 24. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J, Miettinen M.
    Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
    [Abstract] [Full Text] [Related]

  • 25. The role of KIT in the management of patients with gastrointestinal stromal tumors.
    Hornick JL, Fletcher CD.
    Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
    [Abstract] [Full Text] [Related]

  • 26. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM, Lee TE, Syed SA, Burgoyne AM, Leonard SY, Gao F, Chan JC, Shi E, Chmielecki J, Morosini D, Wang K, Ross JS, Kendrick ML, Bardsley MR, Siena M, Mao J, Harismendy O, Ordog T, Sicklick JK.
    Oncotarget; 2016 Nov 29; 7(48):78226-78241. PubMed ID: 27793025
    [Abstract] [Full Text] [Related]

  • 27. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST].
    Gutierrez MR, Dorronsoro ML, Marco AM, Pérez IR, Villegas IA, Virseda JM.
    An Sist Sanit Navar; 2011 Nov 29; 34(2):245-51. PubMed ID: 21904406
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.
    Simon S, Grabellus F, Ferrera L, Galietta L, Schwindenhammer B, Mühlenberg T, Taeger G, Eilers G, Treckmann J, Breitenbuecher F, Schuler M, Taguchi T, Fletcher JA, Bauer S.
    Cancer Res; 2013 Jun 15; 73(12):3661-70. PubMed ID: 23576565
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the Novel Monoclonal Antibody Against DOG1 as a Diagnostic Marker for Gastrointestinal Stromal Tumors.
    Abdel-Hadi M, Bessa SS, Hamam SM.
    J Egypt Natl Canc Inst; 2009 Sep 15; 21(3):237-47. PubMed ID: 21132034
    [Abstract] [Full Text] [Related]

  • 32. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.
    Wada T, Tanabe S, Ishido K, Higuchi K, Sasaki T, Katada C, Azuma M, Naruke A, Kim M, Koizumi W, Mikami T.
    World J Gastroenterol; 2013 Dec 21; 19(47):9133-6. PubMed ID: 24379641
    [Abstract] [Full Text] [Related]

  • 33. Pathology of gastrointestinal stromal tumors.
    Hirota S, Isozaki K.
    Pathol Int; 2006 Jan 21; 56(1):1-9. PubMed ID: 16398673
    [Abstract] [Full Text] [Related]

  • 34. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
    Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H.
    J Clin Oncol; 2005 Jan 01; 23(1):49-57. PubMed ID: 15545668
    [Abstract] [Full Text] [Related]

  • 35. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S, Kitadai Y, Yoshida S, Tanaka S, Yoshihara M, Yoshida K, Chayama K.
    Int J Oncol; 2006 Jun 01; 28(6):1361-7. PubMed ID: 16685437
    [Abstract] [Full Text] [Related]

  • 36. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA.
    Mayr P, Märkl B, Agaimy A, Kriening B, Dintner S, Schenkirsch G, Schneider-Stock R.
    Langenbecks Arch Surg; 2019 Aug 01; 404(5):605-613. PubMed ID: 30877378
    [Abstract] [Full Text] [Related]

  • 37. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features].
    Kovács M, Nagy P, Pák G, Fehér J.
    Orv Hetil; 2005 Jun 26; 146(26):1375-81. PubMed ID: 16052979
    [Abstract] [Full Text] [Related]

  • 38. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
    Agaimy A, Otto C, Braun A, Geddert H, Schaefer IM, Haller F.
    Int J Clin Exp Pathol; 2013 Jun 26; 6(9):1839-46. PubMed ID: 24040448
    [Abstract] [Full Text] [Related]

  • 39. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE, Kim MA, Lee HS, Lee BL, Kim WH.
    J Clin Pathol; 2008 Jun 26; 61(6):722-9. PubMed ID: 18381383
    [Abstract] [Full Text] [Related]

  • 40. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.
    Lee CH, Liang CW, Espinosa I.
    Adv Anat Pathol; 2010 May 26; 17(3):222-32. PubMed ID: 20418677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.